As TRIM proteins act on multiple critical nodes of steroid hormone-dependent carcinogenesis and tumor progression, a deeper mechanistic understanding of TRIM action is critical to fully exploit the clinical potential of TRIMs as drug targets and biomarkers for treatment selection. The gene discussed is TRAT1; the disease is neoplasm.